Tilray

(NASDAQ: TLRY)
Healthcare  |  Drug Manufacturers—Specialty & Generic
8.50 1.03 13.79%
Stock Price | Nov. 27, 2020, 1 p.m.
6 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 7.47
52 Week Low: 2.43
52 Week High: 22.95
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Read more Read less

Recently Viewed Tickers

Premium Weekly Review 11/27/20

Yesterday

Premium Cannabis Stocks Review - AM Edition 11/25/20 - Resent

32 Comments
3 days ago

Premium Cannabis Stocks Review - AM Edition 11/25/20

3 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/25/20

49 Comments
4 days ago

Premium Cannabis Stocks Review - AM Edition 11/24/20

5 Comments
4 days ago

Premium Cannabis Stocks Review - AM Edition 11/23/30

30 Comments
5 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/19/20

2 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 11/16/20

18 Comments
1 week ago

Premium Weekly Review 11/13/20

2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/13/20

6 Comments
2 weeks ago